333 related articles for article (PubMed ID: 7804700)
1. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.
Nalesnik MA; Starzl TE
Transplant Sci; 1994 Sep; 4(1):61-79. PubMed ID: 7804700
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.
Riddler SA; Breinig MC; McKnight JL
Blood; 1994 Aug; 84(3):972-84. PubMed ID: 8043879
[TBL] [Abstract][Full Text] [Related]
3. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
4. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
[No Abstract] [Full Text] [Related]
5. Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation.
Birkeland SA; Bendtzen K; Møller B; Hamilton-Dutoit S; Andersen HK
Transplantation; 1999 Mar; 67(6):876-81. PubMed ID: 10199737
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
[TBL] [Abstract][Full Text] [Related]
7. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
Leblond V; Sutton L; Dorent R; Davi F; Bitker MO; Gabarre J; Charlotte F; Ghoussoub JJ; Fourcade C; Fischer A
J Clin Oncol; 1995 Apr; 13(4):961-8. PubMed ID: 7707124
[TBL] [Abstract][Full Text] [Related]
8. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.
Purtilo DT
Adv Cancer Res; 1981; 34():279-312. PubMed ID: 6269372
[No Abstract] [Full Text] [Related]
9. Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?
Morscio J; Dierickx D; Tousseyn T
Clin Dev Immunol; 2013; 2013():150835. PubMed ID: 23690819
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency.
Cohen JI
Medicine (Baltimore); 1991 Mar; 70(2):137-60. PubMed ID: 1848644
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease.
Kenagy DN; Schlesinger Y; Weck K; Ritter JH; Gaudreault-Keener MM; Storch GA
Transplantation; 1995 Sep; 60(6):547-54. PubMed ID: 7570949
[TBL] [Abstract][Full Text] [Related]
12. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients.
Babcock GJ; Decker LL; Freeman RB; Thorley-Lawson DA
J Exp Med; 1999 Aug; 190(4):567-76. PubMed ID: 10449527
[TBL] [Abstract][Full Text] [Related]
13. [Recent aspects of Epstein-Barr virus infections].
Hasler F
Schweiz Med Wochenschr; 1984 Apr; 114(15):520-3. PubMed ID: 6328644
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant lymphoproliferative disorder.
Basgoz N; Preiksaitis JK
Infect Dis Clin North Am; 1995 Dec; 9(4):901-23. PubMed ID: 8747772
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
[No Abstract] [Full Text] [Related]
16. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.
Savoie A; Perpête C; Carpentier L; Joncas J; Alfieri C
Blood; 1994 May; 83(9):2715-22. PubMed ID: 8167350
[TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus.
List AF; Greco FA; Vogler LB
J Clin Oncol; 1987 Oct; 5(10):1673-89. PubMed ID: 2821199
[TBL] [Abstract][Full Text] [Related]
18. [Post-transplantation lymphomas and Epstein-Barr virus].
Caillard S; Heibel F; Benaicha M; Moulin B
Nephrologie; 1998; 19(8):481-8. PubMed ID: 9894641
[TBL] [Abstract][Full Text] [Related]
19. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients.
Boyle GJ; Michaels MG; Webber SA; Knisely AS; Kurland G; Cipriani LA; Griffith BP; Fricker FJ
J Pediatr; 1997 Aug; 131(2):309-13. PubMed ID: 9290623
[TBL] [Abstract][Full Text] [Related]
20. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
Martinez OM; Krams SM
Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
